Group size experiences with enhanced pre- and postnatal development studies in the long-tailed macaque (<i>Macaca fascicularis</i>)

Luetjens, C. Marc; Fuchs, Antje; Baker, Ann; Weinbauer, Gerhard F.

doi:https://doi.org/10.5194/pb-7-1-2020

Articles | Volume 7, issue 1

https://doi.org/10.5194/pb-7-1-2020

© Author(s) 2020. This work is distributed under
the Creative Commons Attribution 4.0 License.

https://doi.org/10.5194/pb-7-1-2020

© Author(s) 2020. This work is distributed under
the Creative Commons Attribution 4.0 License.

Articles | Volume 7, issue 1

Short communication

|

11 Mar 2020

Short communication |

| 11 Mar 2020

Group size experiences with enhanced pre- and postnatal development studies in the long-tailed macaque (Macaca fascicularis)

C. Marc Luetjens, Antje Fuchs, Ann Baker, and Gerhard F. Weinbauer

Related subject area

Reproductive biology

The use of alfaxalone for short-term anesthesia can confound serum progesterone measurements in the common marmoset: a case report

Maria Daskalaki, Charis Drummer, Rüdiger Behr, and Michael Heistermann

Primate Biol., 9, 23–28, https://doi.org/10.5194/pb-9-23-2022,https://doi.org/10.5194/pb-9-23-2022, 2022

Short summary

Core body temperature is not a reliable parameter to follow the reproductive cycle in female marmoset monkey (Callithrix jacchus)

C. Drummer, J. König, K. Eildermann, E. Fuchs, R. Behr, and K. Hoffmann

Primate Biol., 1, 11–22, https://doi.org/10.5194/pb-1-11-2014,https://doi.org/10.5194/pb-1-11-2014, 2014

Cited articles

Council of Europe: Appendix A of the European convention for the protection of vertebrate animals used for experimental and other scientific purposes (ETS 494 no. 123) – Guidelines for the accommodation and care of animals (Article 5 of the Convention), Council of Europe, Strasbourg, France, ETS No. 123 (2006), effective from 15 July 2007.

ICH M3(R2): Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals, available at: https://database.ich.org/sites/default/files/M3_R2_Guideline.pdf (last access: 3 March 2020), 2009.

ICH S6(R1): Preclinical safety evaluation of biotechnology-derived pharmaceuticals, available at: https://database.ich.org/sites/default/files/S6_R1_Guideline_0.pdf (last access: 3 March 2020), 2011.

Jarvis, P., Srivastav, S., Vogelwedde, E., Stewart, J., Mitchard, T., and Weinbauer, G. F.: The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates and group size considerations, Birth Defects Res. B, 89, 175–187, 2010.

Krejsa, M., Neradilek, M. B., Polissar, N. L., Cox, N., Clark, D., Cowan, L., Bussiere, J., and Lebrec, H.: An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: Flow cytometry immunophenotyping, J. Immunotoxicol., 10, 361–372, 2013.